Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Muller & Phipps (India)'s
Operating Income
for the
three
months ended in Mar. 2026 was ₹-3.90 Mil. Muller & Phipps (India)'s Interest Expense for the
three
months ended in Mar. 2026 was ₹-0.16 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Muller & Phipps (India)'s Interest Coverage or its related term are showing as below:
BOM:501477's Interest Coverage is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 8 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Muller & Phipps (India) Interest Coverage Related Terms
Muller & Phipps (India) Interest Coverage Historical Data
* Premium members only.
The historical data trend for Muller & Phipps (India)'s Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Pharmaceutical Retailers subindustry, Muller & Phipps (India)'s Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Muller & Phipps (India) Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Muller & Phipps (India)'s Interest Coverage distribution charts can be found below:
* The bar in red indicates where Muller & Phipps (India)'s Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Muller & Phipps (India) did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Muller & Phipps (India) (BOM:501477) has a Interest Coverage of 0 (At Loss) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Muller & Phipps (India) and its competitors. According to the industry distribution chart, Muller & Phipps (India) ranks #999999 out of 454 companies in the Healthcare Providers & Services industry.
Is Muller & Phipps (India)'s Interest Coverage too high?
Muller & Phipps (India)'s current Interest Coverage is 0 (At Loss). Based on the distribution chart, Muller & Phipps (India) ranks #999999 out of 454 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Muller & Phipps (India) has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Muller & Phipps (India)'s Interest Coverage compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Muller & Phipps (India) ranks #999999 out of 454 companies for Interest Coverage. This places Muller & Phipps (India) in the lower half of its industry. The industry median Interest Coverage is 8.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 8.00, based on 454 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Muller & Phipps (India) and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Muller & Phipps (India)'s current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Muller & Phipps (India) stock overvalued right now?
Based on GuruFocus' analysis, Muller & Phipps (India) (BOM:501477) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹280.57, compared to a current price of ₹219.95 — trading 21.6% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Muller & Phipps (India)'s overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Muller & Phipps (India) (BOM:501477), the current Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Muller & Phipps (India) (BOM:501477) Overvalued in 2026?
Based on GuruFocus' analysis, Muller & Phipps (India) stock appears to be undervalued.
The current stock price of ₹219.95 is trading 21.6% below its estimated GF Value™ of ₹280.57.
GuruFocus considers Muller & Phipps (India) to be Modestly Undervalued.
Key valuation signals for BOM:501477:
Interest Coverage: 0 (At Loss)
GF Value™: ₹280.57 vs. price of ₹219.95 (21.6% below fair value)
No single metric tells the full story. See the BOM:501477 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Muller & Phipps (India) Ltd is engaged in the marketing of over-the-counter medical preparations and home care products. The operating segments of the company are Cosmetic/toiletry, Medicated preparation, Food Products, and Others, of which a majority of the revenue is derived from the Medical preparation segment. The company's product portfolio includes medicated dental products, ayurvedic skin ointment, and home care products. Its brand names include Cavisan, Cavidine, and Nixoderm.
54GF Score
Get the complete analysis for BOM:501477
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:501477 has been successfully added to your 
